Previous 10 | Next 10 |
INCLINE VILLAGE, Nev. , Dec. 3, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) congratulates Evofem Biosciences, Inc. ("Evofem") (NASDAQ: EVFM) on its recent achievement of two major regulatory and clinical milestones with its lead product candi...
INCLINE VILLAGE, Nev. , Nov. 14, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today issued the following statement in response to Engine Capital LP's ("Engine") escalation of its public campaign criticizing PDL's strategic direction: "PDL values...
NEW YORK , Nov. 14, 2019 /PRNewswire/ -- Engine Capital LP (together with its affiliates, "Engine"), a significant shareholder of PDL BioPharma, Inc. ("PDLI" or the "Company") (Nasdaq: PDLI), with ownership of approximately 5.3% of the Company's outstanding shares, announced today that it...
The following slide deck was published by PDL BioPharma, Inc. in conjunction with their 2019 Q3 earnings Read more ...
Image source: The Motley Fool. PDL Biopharma Inc (NASDAQ: PDLI) Q3 2019 Earnings Call Nov 6, 2019 , 4:30 p.m. ET Operator Continue reading
PDL BioPharma, Inc. (PDLI) Q3 2019 Earnings Conference Call November 6, 2019 4:30 PM ET Company Participants Jody Cain – Senior Vice President-Lippert/Heilshorn & Associates, Inc. Dominique Monnet – President and Chief Executive Officer Ed Imbrogno – Vice...
PDL BioPharma (NASDAQ: PDLI ): Q3 GAAP EPS of -$0.16 misses by $0.21 . Revenue of $44.2M (-34.9% Y/Y) beats by $10.34M . Press Release More news on: PDL BioPharma, Inc., Earnings news and commentary, Healthcare stocks news,
INCLINE VILLAGE, Nev. , Nov. 6, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) reports financial results for the three and nine months ended September 30, 2019 : Third Quarter Financial Highlights Total revenues were $44.2 million , including $2...
INCLINE VILLAGE, Nev. , Oct. 30, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI) today announced that it will release its third quarter 2019 financial results for the period ended September 30, 2019 , on Wednesday, November 6, 2019 , after market cl...
INCLINE VILLAGE, Nev. , Oct. 24, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that Harold E. Selick , Ph.D., Chairman of the Board of Directors of PDL BioPharma, has sent the following letter to Engine Capital, LP. October 24, 2019 ...
News, Short Squeeze, Breakout and More Instantly...
Price matters most to making money in the market. Celebrating 20 years, Stock Traders Daily provides the tools that help you develop investment strategies, and this is a good example. When we couple this with our market based analysis, the probabilities of going with the flow increases, and t...
PDL BioPharma Enters into $51.4 Million Capital Provision Agreement with Epps Investments LLC Regarding PDL's Previously Announced Settlement Agreement with Wellstat RENO, Nev. , Dec. 14, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDL...
Penny Stocks to Watch Today Finding the best penny stocks to buy seems simple, but it takes time to identify a clear trend. We saw this week, how quickly these can breakout. We’ve also seen how quickly they can break down. So deciding what type of trading strategy you’...